A community pharmacy-based program to enhance adherence to adjuvant endocrine therapy among breast cancer survivors (PACHA): protocol for a pilot cluster-randomized controlled trial

Abstract Background Adjuvant endocrine therapy (AET) is an oral treatment prescribed for 5 to 10 years to women with hormone-sensitive breast cancer. Despite the benefits of AET for reducing breast cancer recurrence, suboptimal adherence is common. Community pharmacists can play a role in supporting...

Full description

Saved in:
Bibliographic Details
Main Authors: Julie Lapointe, Laurence Guillaumie, Anne Dionne, Lyne Lalonde, Julie Lemieux, Michel Dorval, Hermann Nabi, Martine Lemay, Line Guénette, Jason Robert Guertin, Benoît Mâsse, Sophie Lauzier
Format: Article
Language:English
Published: BMC 2025-07-01
Series:Pilot and Feasibility Studies
Subjects:
Online Access:https://doi.org/10.1186/s40814-025-01676-8
Tags: Add Tag
No Tags, Be the first to tag this record!